CN116019966B - Wound dressing capable of both discharging tissue fluid and preventing blood scab from sticking and preparation method thereof - Google Patents
Wound dressing capable of both discharging tissue fluid and preventing blood scab from sticking and preparation method thereof Download PDFInfo
- Publication number
- CN116019966B CN116019966B CN202211286925.8A CN202211286925A CN116019966B CN 116019966 B CN116019966 B CN 116019966B CN 202211286925 A CN202211286925 A CN 202211286925A CN 116019966 B CN116019966 B CN 116019966B
- Authority
- CN
- China
- Prior art keywords
- super
- wound dressing
- blood
- hydrophobic
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008280 blood Substances 0.000 title claims abstract description 50
- 210000004369 blood Anatomy 0.000 title claims abstract description 49
- 206010039509 Scab Diseases 0.000 title claims abstract description 30
- 239000012530 fluid Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title abstract description 19
- 238000007599 discharging Methods 0.000 title description 4
- 238000000034 method Methods 0.000 claims abstract description 20
- 230000002265 prevention Effects 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000001764 infiltration Methods 0.000 claims abstract description 3
- 230000008595 infiltration Effects 0.000 claims abstract description 3
- 230000003075 superhydrophobic effect Effects 0.000 claims description 61
- 239000002245 particle Substances 0.000 claims description 35
- 239000005871 repellent Substances 0.000 claims description 34
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 23
- 239000004745 nonwoven fabric Substances 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 19
- 229920000642 polymer Polymers 0.000 claims description 17
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 16
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 16
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- 239000000835 fiber Substances 0.000 claims description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 239000011259 mixed solution Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
- 239000002033 PVDF binder Substances 0.000 claims description 9
- -1 perfluoro octadecyl Chemical group 0.000 claims description 9
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 8
- 229910001220 stainless steel Inorganic materials 0.000 claims description 8
- 239000010935 stainless steel Substances 0.000 claims description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 7
- 238000005553 drilling Methods 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 6
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 6
- 238000010790 dilution Methods 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 5
- 239000006185 dispersion Substances 0.000 claims description 5
- 230000004913 activation Effects 0.000 claims description 4
- 238000001994 activation Methods 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 4
- 238000000576 coating method Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 4
- 229920001610 polycaprolactone Polymers 0.000 claims description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 4
- 238000001132 ultrasonic dispersion Methods 0.000 claims description 4
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 230000002349 favourable effect Effects 0.000 claims description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 239000002086 nanomaterial Substances 0.000 claims description 3
- 229920000098 polyolefin Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- 238000003491 array Methods 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000003825 pressing Methods 0.000 claims description 2
- 210000003722 extracellular fluid Anatomy 0.000 claims 3
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims 2
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 claims 1
- 239000004593 Epoxy Substances 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 118
- 208000027418 Wounds and injury Diseases 0.000 description 118
- 239000002105 nanoparticle Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000004744 fabric Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- PYJJCSYBSYXGQQ-UHFFFAOYSA-N trichloro(octadecyl)silane Chemical compound CCCCCCCCCCCCCCCCCC[Si](Cl)(Cl)Cl PYJJCSYBSYXGQQ-UHFFFAOYSA-N 0.000 description 5
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 4
- 238000010041 electrostatic spinning Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- RSKGMYDENCAJEN-UHFFFAOYSA-N hexadecyl(trimethoxy)silane Chemical compound CCCCCCCCCCCCCCCC[Si](OC)(OC)OC RSKGMYDENCAJEN-UHFFFAOYSA-N 0.000 description 4
- 239000008279 sol Substances 0.000 description 4
- 244000020998 Acacia farnesiana Species 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 239000004626 polylactic acid Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000002134 carbon nanofiber Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 241001552669 Adonis annua Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 229910052681 coesite Inorganic materials 0.000 description 1
- 229910052906 cristobalite Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000010336 energy treatment Methods 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000005055 methyl trichlorosilane Substances 0.000 description 1
- JLUFWMXJHAVVNN-UHFFFAOYSA-N methyltrichlorosilane Chemical compound C[Si](Cl)(Cl)Cl JLUFWMXJHAVVNN-UHFFFAOYSA-N 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 238000000678 plasma activation Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052682 stishovite Inorganic materials 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- RCHUVCPBWWSUMC-UHFFFAOYSA-N trichloro(octyl)silane Chemical compound CCCCCCCC[Si](Cl)(Cl)Cl RCHUVCPBWWSUMC-UHFFFAOYSA-N 0.000 description 1
- 229910052905 tridymite Inorganic materials 0.000 description 1
- 238000004506 ultrasonic cleaning Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Materials For Medical Uses (AREA)
Abstract
本公开提供一种兼具组织液排出和防血痂粘黏的伤口敷料及其制备方法，包括制备原料，制备方法，调控参数。本发明还提供了一种在超疏血伤口敷料上制备亲水阵列的方法。本公开制备的带有亲水点阵的超疏血伤口敷料制备方法简单，可以批量生产，得到的超疏血伤口敷料疏血效果好，能够防止血液浸润，避免血痂黏连，同时具有优良的组织液排出能力与抗菌能力。
The present invention provides a wound dressing that has both tissue fluid discharge and blood scab adhesion prevention and a preparation method thereof, including preparation raw materials, preparation methods, and control parameters. The present invention also provides a method for preparing a hydrophilic array on a super-hemophobic wound dressing. The preparation method of the super-hemophobic wound dressing with a hydrophilic lattice prepared by the present invention is simple and can be mass-produced. The obtained super-hemophobic wound dressing has a good blood-repelling effect, can prevent blood infiltration, avoid blood scab adhesion, and has excellent tissue fluid discharge ability and antibacterial ability.
Description
Technical Field
The invention relates to the field of new materials, in particular to a wound dressing with tissue fluid discharge and blood scab adhesion prevention functions and a preparation method thereof.
Background
The wound is the most common health problem in human life, a plurality of wound dressings with different types and different wound symptoms are widely researched and manufactured, and good effects are achieved, however, more dressings are still medical gauze dressings clinically used at present, and only a small amount of new dressing products can be widely applied to clinical treatment. In use, the medical gauze dressing has good ventilation capability, can absorb tissue fluid and blood of a wound, and has a certain effect of preventing wound infection. But in clinical use, the medical gauze dressing has slower hemostatic speed, does not have the capability of promoting healing and accelerating blood to wounds, is difficult to achieve better effect at a large-area wound part or a wound with large bleeding amount, and can be adhered to the wounds by the formed scab after blood is absorbed by the gauze to coagulate, so that secondary wounds are very easy to occur when the gauze is removed, the secondary bleeding affects wound repair, and the health of a patient is damaged again. Thus, a wound dressing is prepared that prevents adhesion to the wound and is critical to healing after repair of the wound in a patient.
In recent years, there have been some reports on the design of wound dressings from the surface interface point of view, for example, the use of super-hydrophilic graphene sponge to rapidly absorb moisture in blood, form a layer of dense blood cells and platelets, thereby promoting blood coagulation, or the use of β -chitosan coating to enhance blood wettability to promote blood coagulation, etc. Meanwhile, some researchers use hydrophobic wound dressing to play a certain role in preventing adhesion. However, super-hydrophobic wound dressings have the unique advantage of preventing wound adhesion and creating secondary wounds. This is mainly the case when blood exists in a Cassie state on a superhydrophobic surface, fibrin first adsorbs on the superhydrophobic surface and promotes blood coagulation. After the wound is coagulated, an air layer formed by a Cassie state exists on the surfaces of the scab and the wound dressing, so that the scab is prevented from being in direct contact with the wound dressing, and the side effect of secondary bleeding is reduced. The super-hydrophobic wound dressing has the unique effects of promoting the rapid growth of fibrin, realizing rapid coagulation, no blood loss, antibacterial property and thrombus self-separation, has the unique advantages of preparing the super-hydrophobic wound dressing by using Carbon Nanofiber (CNF) doped in Polydimethylsiloxane (PDMS) and Polytetrafluoroethylene (PTFE), and verifies that the wound dressing has a super-hydrophobic surface. However, the super-hydrophobic wound dressing still has some common problems that 1) the common super-hydrophobic wound dressing is poor in stability, cannot drain blood for a long time, is easy to produce secondary wounds after being adhered to the wound after contacting the surface for a certain time, 2) most of the super-hydrophobic medical devices are prepared by using fluorine-containing materials, the fluorine-containing materials and the blood are contacted for a long time, especially fluorine-containing small molecules fall off, and can generate strong toxicity and immune response to organisms, and 3) excessive liquid cannot be discharged when exuding to wound bleeding, suppuration, tissue fluid and the like, so that the coagulation and healing of the wound are affected.
Aiming at the problems, a hydrophilic array with smaller size is introduced into the surface of the super-hydrophobic wound dressing, so that excessive liquid at the wound can be discharged while the blood crust on the surface of the dressing is ensured to be easily removed. Superhydrophobic surfaces are typically obtained by low surface energy treatment. The super-hydrophobic surface is activated or perforated to obtain a hydrophilic array channel capable of enabling liquid to pass through, and then the back side of the super-hydrophobic dressing is subjected to super-hydrophilic modification to enhance the capillary force of the liquid when the liquid passes through the surface of the super-hydrophobic wound dressing.
Disclosure of Invention
In view of the problems that the existing wound dressing is easy to generate secondary wounds when stripped, the blood-repellent effect of the super-repellent wound dressing is unstable, more tissue fluid and blood exist at a wound site to influence wound healing and the like, the present disclosure provides a method for preparing the super-repellent wound dressing and establishing a hydrophilic array on the surface of the super-repellent wound dressing, and the dressing has the capability of draining excessive liquid from the wound while maintaining the super-hydrophobicity of the dressing, and blood crust is easy to strip from the wound after the wound is coagulated, so that secondary wounds at the wound are not caused, and the problems in one aspect or multiple aspects of the prior art are solved.
Aiming at the problems in the prior art, the application provides a wound dressing with tissue fluid discharge and blood crust adhesion prevention, which comprises super-hydrophobic particles, a solvent and a polymer raw material;
super-hydrophobic particles, a micro-nano structure is constructed on the surface of the fiber, and the surface energy is reduced;
the solvent provides environment for dilution, uniform dispersion and mixing of the super-hydrophobic particles and the polymer raw materials, is favorable for infiltration and coating of the mixed solution on the non-woven fabric to prepare the super-hydrophobic wound dressing, and is matched with the polarities of the super-hydrophobic particles and the polymer raw materials.
Preferably, the superhydrophobic particles are one or more of methyl SiO 2 particles, ethyl SiO 2 particles, PDMS modified SiO 2 particles, octadecyl SiO 2 particles, and perfluorooctadecyl SiO 2 particles.
Further, the size of the super-hydrophobic nano-particles is one or more of 10-20nm,200-300nm and 1-10 μm.
Preferably, the solvent is one or more selected from ethyl acetate, butyl acetate, acetone, ethanol, tetrahydrofuran, DMF, DMSO, methyl ethyl ketone, toluene, xylene.
Preferably, the polymer raw material is one or more selected from polyurethane, polyolefin, PDMS, PVDF, PTFE, PCL, PVA, PLA containing curing agent and epoxy resin.
Further, the dilution concentration of the super-hydrophobic particles dissolved in the solvent is 1mg/mL-100mg/mL.
Further, the ratio of the super-hydrophobic particles to the polymer raw material which are diluted and dissolved in the solvent is 50:1-1:50.
Further, the non-woven fabric material is dip-coated in the prepared mixed solution for 5-1000 seconds, or one or more of spray-coating for 5-1000 seconds by using a spray gun and spin-coating.
Further, the non-woven fabric material with the coating is put into an oven for curing and drying, the temperature is set to be 40-120 ℃, and the drying time is set to be 1-48 hours.
The application also relates to a preparation method of the wound dressing with the functions of discharging tissue fluid and preventing blood crust from sticking, which comprises the following steps:
S1, mixing super-hydrophobic particles, a solvent and polymer raw materials in proportion, and uniformly dispersing the mixture by using an ultrasonic cleaner for 10-60 minutes;
S2, cutting the non-woven fabric into proper size, and soaking the non-woven fabric in the mixed solution with complete ultrasonic dispersion for 5-1000 seconds to form the super-blood-repellent non-woven fabric;
S3, taking out the super-blood-repellent non-woven fabric, and drying and curing in a baking oven at 40-120 ℃ to volatilize the solvent completely for 1-48 hours.
The application also relates to a preparation method of the wound dressing with the functions of discharging tissue fluid and preventing blood crust from sticking, which comprises the following steps:
m1, uniformly mixing ethanol, ammonia water, distilled water and Tetraethoxysilane (TEOS), and standing at room temperature to form SiO 2 sol;
M2, soaking the original fiber cloth in SiO 2 sol, drying at room temperature, and curing in an oven;
M3, putting the sample into hexadecyl trimethoxy silane (HDTMS) diluted by ethanol;
And M4, finally curing in an oven to obtain the super-hydrophobic fiber cloth.
The application also relates to a preparation method of the wound dressing with the functions of tissue fluid discharge and blood scab adhesion prevention, which comprises the following steps of adding deionized water into Octadecyl Trichlorosilane (OTS), mixing, standing after ultrasonic treatment, adding n-hexane to terminate the assembly process, standing after uniform mixing, soaking the original fiber cloth in the re-shaking n-hexane dispersion liquid, and drying in a drying oven.
The application also relates to a preparation method of the wound dressing with the functions of tissue fluid discharge and blood scab adhesion prevention, which comprises the following steps of dissolving polyvinylidene fluoride (PVDF) in N, N-Dimethylformamide (DMF), preparing the super-hydrophobic SiO2 nano particles/PVDF into an electrostatic spinning solution, and preparing the super-hydrophobic fiber by using a handheld electrostatic spinning instrument to form the super-hydrophobic wound dressing.
Preferably, the preparation method of the wound dressing with the functions of tissue fluid discharge and blood scab adhesion prevention comprises the following steps:
A4, arranging a pair of needle points on one side of the super-blood-thinning wound dressing, and respectively connecting the positive electrode and the negative electrode of a direct current power supply;
A5, starting a direct current power supply, increasing voltage until the needle tip discharges, and starting counting when air breaks down;
a6, after the discharge breaks down air, hydrophilic points are manufactured on the super-blood-repellent wound dressing;
A4, the super-blood-thinning wound dressing and the needle point relatively move to prepare a hydrophilic dot array.
Preferably, the preparation method of the wound dressing with the functions of tissue fluid discharge and blood scab adhesion prevention comprises the following steps:
B4, manufacturing a stainless steel plate with a preset aperture and a preset distance by using laser drilling;
B5, pressing the super-hydrophobic wound dressing by using the prepared stainless steel plate, and fixing the stainless steel plate and the super-hydrophobic wound dressing;
B6, placing the fixed super-blood-repellent wound dressing in a plasma cleaner for activation to prepare a hydrophilic dot array.
Preferably, the preparation method of the wound dressing with the functions of tissue fluid discharge and blood scab adhesion prevention comprises the following steps:
And C1, horizontally placing the prepared super-blood-repellent wound dressing on a laser object stage.
C2, using Ezcad software to write the punching program.
And C3, starting a laser, and punching the super-blood-repellent wound dressing to prepare a hydrophilic dot array.
Further, in step S2, the aperture range of the laser drilling is 50-1000 μm, the pitch is 500-2000 μm, and the number of laser scans is 10-500.
Compared with the prior art, the wound dressing with the tissue fluid discharge and the blood scab adhesion prevention functions and the preparation method thereof have the following beneficial effects:
1. The method has simple process steps, can super-dredge various wound dressings and has wide application range;
2. the method can successfully increase the stability of the super-blood-repellent wound dressing and ensure the long-term stable blood-repellent of the dressing;
3. The wound dressing prepared by the method can effectively prevent the adhesion of the wound, and scabs are easy to peel off from the wound, so that secondary wounds at the wound are avoided;
4. the wound dressing prepared by the method can ensure that the dressing has the capacity of discharging excessive liquid from a wound while maintaining the super-hemophobic performance of the dressing, thereby being beneficial to the coagulation and healing of the wound;
5. the method disclosed by the invention is prepared by using a fluorine-free material, and has good biocompatibility.
Drawings
The invention will be described in more detail hereinafter on the basis of embodiments and with reference to the accompanying drawings. Wherein:
FIG. 1 shows a schematic representation of the use of a super-phobic wound dressing with a hydrophilic array of the invention;
FIG. 2 shows a picture of the super-phobic wound dressing of the invention under scanning electron microscopy;
FIG. 3 shows the results of water contact angle tests of the super-phobic wound dressing of the invention prepared according to different particle to polymer ratios;
FIG. 4 shows stability and blood thinning effects tests of super-blood thinning wound dressings prepared by different particle to polymer ratios of the present invention;
FIG. 5 shows a scab release force test of the super-phobic wound dressing of the invention;
FIG. 6 shows a photograph of a super-phobic wound dressing of the invention formed into a hydrophilic array by laser drilling and a photomicrograph;
FIG. 7 shows a performance test of the super-hydrophobic wound dressing with hydrophilic array of the present invention, through which blood is exported;
figure 8 shows a diagram of the invention in terms of the attachment of scabs to a dressing as seen in SEM cross-section.
Detailed Description
The invention will be further described with reference to the accompanying drawings.
As shown in FIG. 1, the present invention provides a method for simply preparing a super-hydrophobic wound dressing, comprising super-hydrophobic particles (component A), solvent (component B), and polymer raw material (component C).
Component A
The component A is super-hydrophobic particles, is a basic component for providing super-hemophobic performance, and can construct a micro-nano structure on the surface of the fiber and reduce the surface energy.
Component A may be selected from one or more of methyl SiO 2 particles, ethyl SiO 2 particles, PDMS (polydimethylsiloxane) modified SiO 2 particles, octadecyl SiO 2 particles, perfluorooctadecyl SiO 2 particles, the size of the superhydrophobic nanoparticles may be selected from one or more of 10-20nm,200-300nm,1-10 μm, preferably 10-20nm.
Component B
The component B is a solvent, provides environment for dilution, uniform dispersion and mixing of the component A and the component C, and is favorable for the mixed solution to infiltrate and coat on non-woven fabrics to prepare the super-oleophobic wound dressing.
Suitable component B may be selected based on the polarity of component A and component C. Generally speaking. The component B is one or more selected from ethyl acetate, butyl acetate, acetone, ethanol, tetrahydrofuran, DMF (N, N-dimethylformamide), DMSO (dimethyl sulfoxide), methyl ethyl ketone, toluene and xylene.
Component A is diluted and dispersed in component B in a dilution ratio of 1mg/mL-100mg/mL, preferably 5mg/mL-40mg/mL.
Component C
The component C is a polymer, and the polymer is one or more selected from polyurethane, polyolefin, PDMS (polydimethylsiloxane) containing a curing agent, PVDF (polyvinylidene fluoride), PTFE (polytetrafluoroethylene), PCL (polycaprolactone), PVA (polyvinyl alcohol), PLA (polylactic acid) and epoxy resin.
Method for preparing super-blood-dredging wound dressing
Firstly, the components are mixed according to the proportion, and the ultrasonic cleaner is used for uniformly dispersing the components for 10 to 60 minutes. The ultrasonic dispersion of the solution can lead the polymer and the particles to be uniformly dispersed in the solvent, and can lead the polymer and the particles to be uniformly bonded on the non-woven fabric during the dip-coating of the non-woven fabric, thus preparing the super-blood-repellent wound dressing.
The nonwoven fabric is cut to a proper size and soaked in the mixed solution of the ultrasonic dispersion completion for 5 to 1000 seconds, preferably 60 to 600 seconds.
Taking out the super-blood-repellent non-woven fabric, and drying and curing in a 40-120 ℃ oven, preferably 60-80 ℃ to volatilize the solvent completely, wherein the curing time is 1-48 hours, preferably 4-12 hours.
After the curing process is finished, the temperature of the oven is reduced to room temperature, the object is taken out, and the super-blood-repellent wound dressing is successfully prepared.
The preparation method of the super-blood-dredging wound dressing comprises the following steps:
A mixed solution was prepared by uniformly mixing 25mL of ethanol, 1mL of ammonia water (20% wt), 3.6mL of distilled water, and 11mL of Tetraethoxysilane (TEOS), and standing at room temperature for 2 hours to form a SiO 2 sol. After soaking the original fiber cloth in the SiO 2 sol for 5min, it was dried at room temperature for 24h and cured in a 160 ℃ oven for 5min. And then placing the sample into hexadecyl trimethoxy silane (HDTMS) diluted to 4% by ethanol for 4 hours, and finally curing the sample in a 120 ℃ oven for 1 hour to obtain the super-hydrophobic fiber cloth.
A preparation method of the super-blood-dredging wound dressing comprises the following steps:
mu.L of deionized water was added to 1mL of Octadecyl Trichlorosilane (OTS), mixed and sonicated for 30min, then allowed to stand for 90min, 10mL of n-hexane was added to terminate the assembly process, and after uniform mixing, allowed to stand overnight. And (3) soaking the original fiber cloth in the re-shaking normal hexane dispersion liquid for 10 seconds, and drying in a 60 ℃ oven to successfully prepare the super-hydrophobic fiber cloth.
A preparation method of the super-blood-dredging wound dressing is four:
polyvinylidene fluoride (PVDF) is dissolved in N, N-Dimethylformamide (DMF) according to the proportion of 5.0%,7.5%,10.0%,12.5% and 15.0% by weight, and then is prepared into an electrostatic spinning solution according to the proportion of 0.5%,1.0%,2.0%,3.0% and 5.0% by weight (super-hydrophobic SiO 2 nano particles/PVDF), and then super-hydrophobic fibers are prepared by using a handheld electrostatic spinning instrument, so that the super-hydrophobic wound dressing is formed.
Method for preparing super-blood-repellent wound dressing with hydrophilic array
The present disclosure also provides various methods of preparing hydrophilic arrays on superhydrophobic wound dressings, suitable for use with a variety of nonwoven fiber dressings.
Electric breakdown method:
The prepared super-blood-repellent wound dressing is horizontally placed on a platform, and the lower part of the platform and the upper end of the bracket are exposed with a needle point and are connected with the anode and the cathode of a direct current power supply. The needle point on the platform is contacted with the super-blood-thinning wound dressing, and the distance between the needle point at the upper end and the dressing is 1-10cm, preferably 3-7cm. And starting a direct current power supply, increasing the voltage until the needle tip discharges, wherein the voltage range of the direct current power supply is 8-15kv, and starting counting when air is broken down. The number of discharge breakdowns is 10 to 500, preferably 60 to 120. A hydrophilic point is formed on the super-blood-repellent wound dressing after the discharge breaks down the air. And translating the platform or the fiber cloth by a certain size to prepare the hydrophilic dot array.
Plasma activation method:
Stainless steel plates with different pore diameters and different distances are manufactured by laser drilling, wherein the pore diameter range of the laser drilling is 10-1000 mu m, the interval is 500-20000 mu m, the preferred pore diameter range is 200-500 mu m, and the interval is 10000-15000 mu m. The prepared super-hydrophobic wound dressing is pressed by the prepared stainless steel plate and fixed by a clip. The clamped super-phobic wound dressing is placed in a plasma cleaner for activation for 30-1000 seconds, and preferably for 60-180 seconds, so as to prepare a hydrophilic dot array.
Laser method:
And (5) placing the prepared super-blood-repellent wound dressing on a laser object stage. The puncturing program is written using Ezcad software from a computer. The laser perforation has a pore diameter ranging from 50 to 1000 μm, a pitch ranging from 500 to 2000 μm, a number of laser scans ranging from 10 to 500, preferably a pore diameter ranging from 200 to 500 μm, a pitch ranging from 1000 to 1500 μm, and a number of laser scans ranging from 100 to 300. Starting a laser to perform laser perforation on the super-blood-repellent wound dressing to prepare a hydrophilic dot array.
Embodiments of the present disclosure will be described in detail below with reference to examples, but it will be understood by those skilled in the art that the following examples are merely illustrative of the present disclosure and should not be construed as limiting the scope of the present disclosure. The specific conditions are not noted in the examples and are carried out according to conventional conditions or conditions recommended by the manufacturer. The reagents or apparatus used were conventional products commercially available without the manufacturer's attention.
Example 1
The commercially available SiO 2 was hydrophobically modified, and due to the hydrophilic nature of SiO 2, reagents such as methyltrichlorosilane, octyltrichlorosilane, octadecyltrichlorosilane, polydimethylsiloxane were used, and the SiO 2 particles were diluted into the solvent at a ratio of reagent=10:1. The solvent is a reagent with similar polarity to the reagent, such as n-hexane, ethanol, ethyl acetate, toluene, etc. After stirring for 2-6 hours, volatilizing the solvent by using a vacuum drying oven at 60-80 ℃ to obtain the super-hydrophobic nano particles.
Example 2
20ML of the mixed solution (20 mg/mL of the super-hydrophobic nanoparticles, wt% of the super-hydrophobic nanoparticles: PDMS wt% = 5:1, wt% of PDMS curing agent wt% = 10:1, solvent ethyl acetate) was prepared. Ultrasonic cleaning is carried out for 20 minutes by using an ultrasonic cleaner, so that the polymer and the super-hydrophobic nano particles are uniformly mixed and dispersed.
Taking cut non-woven fabrics with the length of 5cm and the length of 5cm, soaking in the prepared mixed solution. After 5 minutes, the non-woven fabric is taken out, put into a 60 ℃ oven for drying and curing for 8 hours, after the curing is finished, the non-woven fabric is taken out and cooled to room temperature, pressed to be flat and subjected to subsequent testing.
As shown in fig. 2, the random positions of the samples were randomly selected, and it was observed by using a scanning electron microscope that the surface of the super-hydrophobic wound dressing had a remarkable rough structure formed of super-hydrophobic nanoparticles, while the surface of the non-woven fabric which was not dip-coated was smoother.
Example 3
The experimental procedure and operational procedure were the same as in example 1, but the ratio of wt% of superhydrophobic nanoparticles to wt% of PDMS in example 1 was modified to be 30:1,20:1,15:1,10:1,5:1,4:1,3:1,2:1,1:1,1:2. After the preparation of the super-blood-dredging wound dressing is completed, the subsequent test is carried out.
As shown in figure 3, different positions are randomly selected, and the contact angle is tested by using a water contact angle meter, so that the test result shows that the prepared super-blood-repellent wound dressing has good super-blood-repellent performance.
Example 4
The fresh pig blood added with the sodium citrate anticoagulant is dripped into the super-blood-repellent wound dressing, after standing for 2 hours at room temperature, the dressing is inclined to enable the blood to slide away, the residual blood on the surface of the wound dressing is observed, as shown in fig. 4, the observation result shows that the super-blood-repellent wound dressing has better long-term blood-repellent capacity.
Example 5
Fresh pig blood added with sodium citrate anticoagulant is used, 20 mu L of the fresh pig blood is dripped onto the super-blood-repellent wound dressing, a thin iron wire is added into the blood, and the blood is stood for 12 hours at room temperature, so that blood is coagulated on the super-blood-repellent wound dressing to form scabs. The eschar release force of the super-phobic wound dressing surface was tested using a universal mechanical tester, as shown in figure 5. Experimental results show that the blood crust breaking force condensed on the surface of the super-blood-repellent wound dressing is extremely small, and secondary wounds are difficult to generate in practical application. And the blood crust release force condensed on the surface of the hydrophobic dressing is obviously larger than that of the super-hydrophobic dressing. (PDMS group is hydrophobic dressing, PDMS particle group is super-hydrophobic group without polymer added)
Example 6
And (3) placing the prepared super-blood-repellent wound dressing on a laser object stage, and programming a punching program by using Ezcad software. The aperture range of the laser drilling is 500 μm, the hole center distance is 2000 μm, and the laser scanning times are 300 times. The laser is turned on to perforate the super-phobic wound dressing to produce an array of hydrophilic spots. The hydrophilic array of the super-phobic wound dressing was recorded by photograph and optical microscopy as shown in fig. 6. The observation result shows that the super-blood-thinning wound dressing is penetrated by high heat of laser, and the hydrophilic dot array is prepared.
Example 7
A super-phobic wound dressing containing a hydrophilic array is placed over a device containing through holes, and a band-aid is prevented from over the dressing for absorbing excess blood that is being drained and compacted with a glass sheet, as shown in fig. 7. The control group is a super-blood-repellent wound dressing without a hydrophilic array and a super-blood-repellent wound dressing without a band-aid. Blood (flow rate 5 mL/min) was injected into the device using a syringe pump, and the blood flowed out of the through-hole of the device and contacted the wound dressing, as shown in fig. 7. Experimental results indicate that the hydrophilic array can draw out excess blood, which can be absorbed by the hydrophilic layer (band-aid).
Example 8
20 Mu L of fresh pig blood added with sodium citrate anticoagulant is dripped on the surface of the super-phobic blood wound dressing, standing and coagulating are carried out at 37 ℃ to form scabs, and the connection part of the scabs and the dressing is observed through an SEM section, so that the super-phobic blood fibers are not infiltrated by blood even under the action of the gravity of the blood, the blood drops can be lifted, and the Cassie state is maintained stable, as shown in figure 8.
Although the invention herein has been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present invention. It is therefore to be understood that numerous modifications may be made to the illustrative embodiments and that other arrangements may be devised without departing from the spirit and scope of the present invention as defined by the appended claims. It should be understood that the different dependent claims and the features described herein may be combined in ways other than as described in the original claims. It is also to be understood that features described in connection with separate embodiments may be used in other described embodiments.
Claims (6)
1. A wound dressing with tissue fluid discharge and blood scab adhesion prevention functions is characterized in that the back side of a super-hydrophobic dressing is subjected to super-hydrophilic modification, a plurality of hydrophilic arrays are obtained in the super-hydrophobic dressing through activation or perforation and used for enhancing capillary force when fluid passes through the surface of the super-hydrophobic wound dressing;
the super-hydrophobic particles construct a micro-nano structure on the surface of the fiber and reduce the surface energy;
The solvent provides environment for dilution, uniform dispersion and mixing of the super-hydrophobic particles and the polymer raw materials, and is favorable for infiltration and coating of the mixed solution on non-woven fabrics to prepare the super-hydrophobic wound dressing;
The super-hydrophobic particles are one or more of methyl SiO 2 particles, octyl SiO 2 particles, PDMS modified SiO 2 particles, octadecyl SiO 2 particles and perfluoro octadecyl SiO 2 particles.
2. The wound dressing having both interstitial fluid drainage and anti-scab adhesion properties according to claim 1, wherein the solvent is one or more selected from the group consisting of ethyl acetate, butyl acetate, acetone, ethanol, tetrahydrofuran, DMF, DMSO, methyl ethyl ketone, toluene, xylene.
3. The wound dressing having both interstitial fluid drainage and anti-scaling properties according to claim 1, wherein the polymeric material is one or more selected from the group consisting of polyurethane, polyolefin, PDMS, PVDF, PTFE, PCL, PVA, PLA containing a curing agent, epoxy.
4. The method for preparing a wound dressing having both interstitial fluid drainage and anti-scab adhesion according to claim 1, comprising the steps of:
s1, mixing super-hydrophobic particles, a solvent and polymer raw materials in proportion, and uniformly dispersing the mixture by using an ultrasonic cleaner;
s2, cutting the non-woven fabric into a proper size, and soaking the non-woven fabric in a mixed solution with complete ultrasonic dispersion to form the super-blood-thinning non-woven fabric;
And S3, taking out the super-blood-repellent non-woven fabric, and drying and solidifying in an oven to volatilize the solvent completely.
5. The method of manufacturing according to claim 4, comprising the steps of:
A4, arranging a pair of needle points on one side of the super-blood-thinning wound dressing, and respectively connecting the positive electrode and the negative electrode of a direct current power supply;
A5, starting a direct current power supply, increasing voltage until the needle tip discharges, and starting counting when air breaks down;
a6, after the discharge breaks down air, hydrophilic points are manufactured on the super-blood-repellent wound dressing;
a7, the super-blood-thinning wound dressing and the needle point relatively move to prepare a hydrophilic point array.
6. The method of manufacturing according to claim 4, comprising the steps of:
B4, manufacturing a stainless steel plate with a preset aperture and a preset distance by using laser drilling;
B5, pressing the super-hydrophobic wound dressing by using the prepared stainless steel plate, and fixing the stainless steel plate and the super-hydrophobic wound dressing;
B6, placing the fixed super-blood-repellent wound dressing in a plasma cleaner for activation to prepare a hydrophilic dot array.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211286925.8A CN116019966B (en) | 2022-10-20 | 2022-10-20 | Wound dressing capable of both discharging tissue fluid and preventing blood scab from sticking and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211286925.8A CN116019966B (en) | 2022-10-20 | 2022-10-20 | Wound dressing capable of both discharging tissue fluid and preventing blood scab from sticking and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116019966A CN116019966A (en) | 2023-04-28 |
| CN116019966B true CN116019966B (en) | 2025-03-25 |
Family
ID=86071259
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211286925.8A Active CN116019966B (en) | 2022-10-20 | 2022-10-20 | Wound dressing capable of both discharging tissue fluid and preventing blood scab from sticking and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116019966B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3838692A (en) * | 1972-11-27 | 1974-10-01 | Johnson & Johnson | Hydrophobic sheet with hydrophilic passages |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4735843A (en) * | 1986-12-18 | 1988-04-05 | The Procter & Gamble Company | Selectively surface-hydrophilic porous or perforated sheets |
| JP2719671B2 (en) * | 1989-07-11 | 1998-02-25 | 日本ゼオン株式会社 | Wound dressing |
| US9035122B2 (en) * | 2012-03-05 | 2015-05-19 | Polyremedy, Inc. | Wound dressing inhibiting lateral diffusion of absorbed exudate |
| CN105727346B (en) * | 2016-02-04 | 2019-08-27 | 中国科学院化学研究所 | A kind of hemostatic fabric and its preparation method and application |
| GB201903387D0 (en) * | 2019-03-12 | 2019-04-24 | Univ Liverpool | Improvements relating to superhydrophobic surfaces |
| US20220241455A1 (en) * | 2021-02-04 | 2022-08-04 | Nan Liu Enterprise Co., Ltd. | Wound dressing |
| CN114470296B (en) * | 2022-01-25 | 2023-03-14 | 珠海钛丰生物科技有限公司 | Stable and super-strong antibacterial super-blood-dredging dressing and preparation method thereof |
-
2022
- 2022-10-20 CN CN202211286925.8A patent/CN116019966B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3838692A (en) * | 1972-11-27 | 1974-10-01 | Johnson & Johnson | Hydrophobic sheet with hydrophilic passages |
Non-Patent Citations (1)
| Title |
|---|
| Superhydrophobic coating constructed from rosin acid and TiO2 used as blood repellent dressing;Wang Y , et al;Social Science Electronic Publishing;20220822;第2页第2栏和第3页第1栏 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116019966A (en) | 2023-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104511045B (en) | A kind of preparation method of the polyvinyl alcohol containing nano silver/chitosan nano fiber membrane dressing | |
| Chen et al. | Pectinate nanofiber mat with high absorbency and antibacterial activity: A potential superior wound dressing to alginate and chitosan nanofiber mats | |
| CN111012941A (en) | Electrostatic spinning double-layer long-acting antibacterial medical dressing and preparation method thereof | |
| CN107320787B (en) | Porous fiber membrane material for periodontal repair and preparation method thereof | |
| CN109267240B (en) | A kind of chitosan/calcium alginate needle-free electrospinning nanofiber membrane for medical dressing and preparation method thereof | |
| CN104436281A (en) | Preparation method of porous sodium alginate nano-fiber wound dressing | |
| CN114470296B (en) | Stable and super-strong antibacterial super-blood-dredging dressing and preparation method thereof | |
| CN116019966B (en) | Wound dressing capable of both discharging tissue fluid and preventing blood scab from sticking and preparation method thereof | |
| CN107974831B (en) | Calcium alginate modified polypropylene fiber non-woven fabric and preparation method thereof | |
| Miller et al. | Conductive nonwoven carbon nanotube-PLA composite nanofibers towards wound sensors via solution blow spinning | |
| CN115887736A (en) | Hemostatic fibrous membrane with asymmetric structure and preparation method thereof | |
| CN102251393A (en) | Surface modification method of aliphatic polyester electrospun fiber by using sodium alginate and gelatin | |
| CN100434455C (en) | A preparation method of degradable polymer wire template with uniform size | |
| Fang et al. | Amphiphilic Janus cotton gauze with enhanced moisture management and blood coagulation for rapid hemostasis and wound healing | |
| CN102808286B (en) | Epoxy resin nanometer fiber felt and preparation method thereof | |
| CN109876180A (en) | A kind of medical porous fiber membrane and preparation method thereof | |
| CN110180013A (en) | Overlay film type medical burn prevents adhesion the preparation method and products thereof and application of type gauze bandage | |
| CN117679548A (en) | A nanofiber cryogel dressing and its preparation and application | |
| CN110424059B (en) | A kind of biopolymer ultrafine fiber prepared based on centrifugal spinning and preparation method thereof | |
| CN115814140B (en) | Antibacterial wound dressing with both drainage and anti-adhesion functions and preparation method thereof | |
| CN107476045A (en) | A kind of preparation method of vacuum plasma modified polypropene non-woven fabrics | |
| CN113908325A (en) | Low-adhesion blood loss-resistant hemostatic material and preparation method and application thereof | |
| CN115282347A (en) | A kind of medical negative pressure drainage tube and preparation method of surface coating thereof | |
| CN104857553A (en) | Preparation method of medical dressing | |
| JP2006133143A (en) | Plasma or serum holding material and blood separation device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |